+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sleep Aids in Saudi Arabia

  • ID: 1954852
  • Report
  • October 2019
  • Region: Saudi Arabia
  • 17 pages
  • Euromonitor International
1 of 2
Value sales continue to decline in Saudi Arabia in 2019 as prices rise on the back of the introduction of VAT over 2017-2018. As a result, increasing price sensitivity meant that sales continued to suffer. Sleep aids comprise mostly of acetaminophen plus diphenhydramine drugs such as Panadol Night and Adol PM, which are listed under human drugs by the Saudi Food & Drug Authority (SFDA) and therefore do not incur the 5% VAT.

The author's Sleep Aids in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Sleep Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
Sleep Aids in Saudi Arabia

List of Contents and Tables
Headlines
Prospects
Value Sales Decline Due To Rising Prices and Lack of Product Awareness
Increasing Stress Continues To Influence Sleeping Patterns
Competitive Landscape
Gsk Consumer Healthcare Dominates Thanks To Strength of Panadol Night
Chemists/pharmacies Dominate Distribution in 2019
Category Data
Table 1 Sales of Sleep Aids: Value 2014-2019
Table 2 Sales of Sleep Aids: % Value Growth 2014-2019
Table 3 NBO Company Shares of Sleep Aids: % Value 2015-2019
Table 4 LBN Brand Shares of Sleep Aids: % Value 2016-2019
Table 5 Forecast Sales of Sleep Aids: Value 2019-2024
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2019-2024
Executive Summary
Higher Prices Continue To Hinder Value Growth in 2019
Increasing Regulation Dampens Present and Future Growth
Gsk Consumer Healthcare Leads Thanks To Well-known Brands and Saudi Investment
New Players Enter Internet Retailing in 2019 Adding New Dynamism To the Market
Value Sales To Pick Up Despite Higher Prices and Expatriates Leaving the Country
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll